LONDON (MarketWatch) -- Pharmaceutical firm AstraZeneca Plc on Thursday reported a 1% slip in fourth-quarter net profit to $1.25 billion, and said it would lay off an additional 7,400 employees by 2013 as it deepens its restructuring program to achieve annual cost savings of around $2.95 billion.
